See Who is Merging, Licensing or Gaining Financial Grants - Pharmaceutical Industry Review
Main Category: Pharma Industry / Biotech IndustryArticle Date: 03 Apr 2005 - 19:00 PDT
'See Who is Merging, Licensing or Gaining Financial Grants - Pharmaceutical Industry Review'
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Research and Markets has announced the addition of Pharmaceutical Industry Partneringreview Annual Review 2004 -- Volume 3 Deals by Transaction Type to their offering.
http://www.researchandmarkets.com/reports/c15013
Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? This report brings all the year's deals into focus in one place.
This volume is a subset of a five volume set. Pharmaceutical Industry Partneringreview Annual Review 2004 is the full report of all the deals data collected in 2004, providing a broad perspective of deal announcements, and incorporates all five volumes.
Scope of this Volume 3: Deals by transaction type
Access deal information by type of transaction -- see who is merging, licensing or gaining financial grants. These are further listed by industry sector, therapy area and stage of development.
Topics covered in this volume include:
- Licensing
- Marketing and promotion
- Supply and distribution
- Collaborative R&D
- Deals listing
Other volumes in the series include:
Volume 1: Industry sector
A summary of over 2,500 deal announcements by nine industry sectors, including a breakdown by therapy area, deal type and stage of development.
Volume 2: Therapy area
Deals by fourteen therapeutic sectors, from autoimmune disease to trauma, with classification by industry sector, deal type and stage of development.
Volume 4: Stage of development
A review of deals by stage of development -- appreciate how deal values change from discovery to launch.
Volume 5: Company deals
A comprehensive overview listing deals by company, with a full index of all the deals announced in 2004. A clear and easy way to see the activities of any company.
Scope of report:
- Fully categorized deal overviews
- Financial information where disclosed
- Specialized indexes including deal type, therapy area, industry sector and stage of development
- An alphabetical index of company activity
This report is essential reading for individuals responsible for and interested in:
- Board and executive management
- Business development
- Licensing/partnering
- Deal making
- Business strategy
- Marketing and promotion
- Distribution and manufacturing (including contract services)
For more information visit
http://www.researchandmarkets.com/reports/c15013
Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980
Research and Markets
http://www.researchandmarkets.com/reports/c15013
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
26 May. 2012. <http://www.medicalnewstoday.com/releases/22169.php>
APA
http://www.medicalnewstoday.com/releases/22169.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'See Who is Merging, Licensing or Gaining Financial Grants - Pharmaceutical Industry Review'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



